| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |